Edwards Lifesciences Hits Day High with Strong 3.1% Intraday Surge

Edwards Lifesciences Corp. has shown significant activity today, with the stock rising by 3.1% as of May 22, 2026. The stock reached an intraday high of USD 86.03, reflecting a positive trend in its performance metrics. Over the past week, Edwards Lifesciences has outperformed the S&P 500, gaining 5.41% compared to the index's 0.88% increase. In terms of longer-term performance, the stock has delivered a 14.69% return over the past year, although it lags behind the S&P 500's 27.93% gain during the same period. Year-to-date, the stock has seen a modest increase of 0.62%, while the S&P 500 has risen by 9.17%. Financially, Edwards Lifesciences boasts a high return on equity (ROE) of 22.80%, indicating strong management efficiency. The company maintains a low debt-to-equity ratio, which is favorable for its financial health. Despite some fluctuations in operating cash flow and profitability, the stock is trading at a fair valuation relative to its peers. Overall, Edwards Lifesciences continues to demonstrate resilience in the pharmaceuticals and biotechnology sector.